
Tropical Diseases
Articles
-
2 months ago |
genomemedicine.biomedcentral.com | Tropical Diseases |Simon Fraser
We compared the accuracy of our new tool, MixInfect2, against previous methods (MixInfect [6], SplitStrains [16], and QuantTB [18]) for detecting mixed infections and to estimate the major strain proportion from the dataset of 36 in vitro mixed samples and 12 non-mixed (“pure”) strains. The average coverage in all these samples was relatively high, ranging from 356- to 482-fold.
-
Jan 15, 2025 |
academic.oup.com | Malawi-Liverpool-Wellcome Programme |Tropical Diseases |Thomas A
Cryptococcal meningitis causes up to 19% of all AIDS-related deaths globally [1]. In recent studies of human immunodeficiency virus (HIV)-associated cryptococcal meningitis, more than half of participants were antiretroviral therapy (ART)-experienced (currently receiving or previously received ART) when developing meningitis [2,3].
-
Jan 10, 2025 |
thelancet.com | Dora Buonfrate |Tropical Diseases |Negrar di Valpolicella
References1. WHOEnding the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021–20302. Clarke, NE ∙ Doi, SAR ∙ Wangdi, K ∙ et al. Efficacy of anthelminthic drugs and drug combinations against soil-transmitted helminths: a systematic review and network meta-analysisClin Infect Dis. 2019; 68:96-1053. Krolewiecki, A ∙ Kepha, S ∙ Fleitas, PE ∙ et al.
-
Jan 7, 2025 |
academic.oup.com | Tropical Diseases
Ye Sun, Qingling Chen, Yuxiao Liu, Mengfan Jiao, Zixing Dai, Xiaoxue Hou, Rui Liu, Yuwen Li, Chuanlong Zhu, Decanoylcarnitine improves liver mitochondrial dysfunction in hepatitis B virus infection by enhancing fatty acid β-oxidation, The Journal of Infectious Diseases, 2025;, jiaf014, https://doi.org/10.1093/infdis/jiaf014 Close You do not currently have access to this article.
-
Dec 9, 2024 |
journals.plos.org | Priyanka Sivakumaran |Barbara de Barros |Tropical Diseases |Universidade Federal Fluminense
DiscussionWe report good clinical outcome in a cohort of 29 individuals who received mROM for leprosy and were followed for a median period of 3.1 years. The proportion of individuals who experienced a leprosy reaction was 58.6% which is consistent with leprosy reaction rates of approximately 65% at three years in a large Brazilian cohort of individuals with MB leprosy treated with WHO MDT containing rifampicin, clofazimine and dapsone for six or 12 months [5].
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →